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Abstract
Introduction: In 1973, Petrea Jacobsen described the first patient showing dysmorphic features, developmental
delay and congenital heart disease (atrial and ventricular septal defect) associated to a 11q deletion, inherited from
the father. Since then, more than 200 patients have been reported, and the chromosomal critical region responsible
for this contiguous gene disorder has been identified.
Patients’ presentation: We report on two unrelated newborns observed in Italy affected by Jacobsen syndrome
(JBS, also known as 11q23 deletion). Both patients presented prenatal and postnatal bleeding, growth and
developmental delay, craniofacial dysmorphisms, multiple congenital anomalies, and pancytopenia of variable
degree. Array comparative genomic hybridization (aCGH) identified a terminal deletion at 11q24.1-q25 of 12.5 Mb
and 11 Mb, in Patient 1 and 2, respectively. Fluorescent in situ hybridization (FISH) analysis of the parents
documented a de novo origin of the deletion for Patient 1; parents of Patient 2 refused further genetic
investigations.
Conclusions: Present newborns show the full phenotype of JBS including thrombocytopenia, according to their
wide 11q deletion size. Bleeding was particularly severe in one of them, leading to a cerebral hemorrhage. Our
report highlights the relevance of early diagnosis, genetic counselling and careful management and follow-up of
JBS patients, which may avoid severe clinical consequences and lower the mortality risk. It may provide further
insights and a better characterization of JBS, suggesting new elements of the genotype-phenotype correlations.
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Introduction
Jacobsen syndrome (JBS; MIM 147791), also known as
11q23 deletion, is a rare contiguous gene syndrome with
about 200 patients reported to date [1]. It has a preva-
lence estimated around 1 in 100,000 newborns, and a fe-
male/male ratio 2:1 [2]. The deletion size ranges from
about 7Mb to 20Mb, between sub band 11q23.3 and
the telomere [3]. The majority of cases (85–92%) has a
de novo origin, while 8–15% are caused by a deletion
due to parental balanced chromosome translocation, or
other rearrangements [3]. Main clinical features are
growth (pre- and postnatal) and developmental delay,
craniofacial dysmorphisms and blood (thrombocytopenia
or pancytopenia) disorders. Malformations of heart, uro-
genital and gastrointestinal tracts, brain and skeleton
may also be observed, as well as ocular, hearing, im-
munological and hormonal defects [2, 3]. Phenotypic
variability depends on type and number of deleted genes
[2, 4]. 20% of patients die during the first 2 years of life
for complications from congenital heart disease (CHD)
or, less commonly, from bleeding [3].
We report on two unrelated newborns with 11q23
deletion syndrome observed in Italy. Our report
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highlights the importance of early diagnosis, genetic
counselling and careful management of JBS patients.
Multidisciplinary and long-term follow-up should be
guaranteed to these subjects, oriented to avoid or antici-
pate possible severe clinical consequences (anemia,
thrombocytopenia, infections due to immunological
deficit), and lower the mortality risk.
Patients’ presentation
Patient 1
A female newborn, second child of healthy Italian non-
consanguineous parents, was delivered at 37+ 4 weeks of
gestation by cesarean section for fetal growth restriction
(FGR) and polyhydramnios. Apgar scores were 6 and 8,
at 1 and 5min respectively. Anthropometric measure-
ments at birth were as follows: weight 1980 g (1st centile,
− 2.37 SD), length 46 cm (12th centile) and occipitofron-
tal circumference (OFC) 31.3 cm (5th centile, − 1.67 SD).
After birth, she suffered from respiratory distress syn-
drome, which needed noninvasive mechanical ventilation
until the 7th day of life. On day 1, cutaneous petechiae
were observed on the trunk, revealing a subtending
thrombocytopenia (platelet count < 50,000/μL) which re-
quested platelet transfusions. During the following 2
days, also anemia and coagulative alterations occurred,
requiring red blood cells and plasma transfusions. The
subsequent clinical course was characterized by a bacter-
ial infection, treated with intravenous antibiotics until
day 13, as well as feeding problems and persistent
thrombocytopenia. At 2 weeks of life she was transferred
to our Department, to deepen the genetic diagnostic
work-up. At admission, physical examination showed:
pale skin, multiple hematomas and signs of venipuncture
on the limbs, brachycephaly with high prominent fore-
head and flattened occiput, and facial dysmorphisms
(posteriorly rotated ears, ocular hypertelorism, alternat-
ing divergent strabismus, broad and flat nasal bridge,
anteverted nares, prominent columella, long and hypo-
plastic philtrum, cleft palate, V-shaped mouth and thin
upper lip, retrognathia) (Fig. 1a/b). Finger alterations (bi-
lateral clinodactyly of the fifth one, enlargement and ad-
duction of the thumbs), bilateral pes equinus varus and
crowded toes were also observed (Fig. 2a/b). Generalized
hypotonia and feeding difficulties completed her clinical
profile. Abdominal ultrasonography (US) revealed bilat-
eral II degree hydronephrosis (according with radiology
grading system), with renal pelvis dilation, in the antero-
posterior diameter, of 7 and 10 mm of the left and right
kidney respectively. Urine analysis and renal function
tests were normal. US heart evaluation showed atrial
septal defect (ASD) and patent ductus arteriosus.
aCGH analysis (100–150 Kb resolution, genomic as-
sembly GRCh37.p13) identified an 11q24.1-q25 deletion
of 12.5 Mb, and indicated the positions 122,293,668 and
134,868,407 as the breakpoints of the rearrangement.
The deleted region involved around a hundred genes, in-
cluding among others JHY, BSX, NRGN, FEZ1, CHEK1,
ETS1, FLI1, KCNJ1, ARHGAP32, ADAMTS8, JAM3 and
B3GAT1. FISH was then performed in both parents,
showing normal results and, thus, confirming a de novo
origin of the genetic abnormality. The patient recovered
from the initial feeding difficulties at around 1 month of
life. Hearing screening through transient-evoked oto-
acoustic emissions (TEOAEs) revealed abnormal results.
In order to ascertain and characterize the hearing loss,
an audiological assessment was started. It included to
date auditory brainstem response (ABR), which showed
bilateral mild conductive hypoacusis. During the second
month of life thrombocytopenia persisted (platelet count
never lower than 30,000/μL, and not associated with
other hematological alterations), however without fur-
ther episodes of bleeding. She was discharged at 2
months of age, and included in a multidisciplinary
follow-up. She currently is 5 months old, and her
Fig. 1 a/b Patient 1. a cleft palate; b lateral view, brachycephaly with flattened occiput, posteriorly rotated ear and retrognathia
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anthropometric measures are: weight 4160 g (<3rd cen-
tile), length 58 cm (<3rd centile) and OFC 39 cm (3rd
centile) (according to World Health Organization
growth chart for neonatal and infant close monitoring)
[5]. She has global developmental delay, mild axial hypo-
tonia and hypertonia of the scapular and pelvic girdles.
Osteotendinous and archaic reflexes are normal. Blood
examination shows thrombocytopenia (86,000/μL) and
normal total immunoglobulin levels. Abdominal US
reveals a bilateral decrease of calico pelvic dilation to 5
and 6mm (anteroposterior diameter) of the left and
right kidney, respectively.
Patient 2
A female newborn, second child of healthy nonconsan-
guineous Eastern european (Ukrainian mother and Esto-
nian father) parents, was delivered at 34+ 5 weeks of
gestation, by spontaneous vaginal birth for preterm
labor. Pregnancy was complicated by threatened miscar-
riage at 26 and 30 weeks of gestation, leading to steroidal
prophylaxis of respiratory distress syndrome. Apgar
scores were 9, 9 and 10, at 1, 5 and 10 min respectively.
Anthropometric measurements at birth were as follows:
weight 1927 g (18th centile), length 41 cm (4th centile)
and OFC 32 cm (59th centile). Physical examination
showed: turricephaly, high prominent forehead, and fa-
cial dysmorphisms (small, low set and posteriorly rotated
ears with hypoplastic antihelix, ocular hypertelorism,
thinned iris, epicanthal folds, down slanting palpebral
fissures, broad nasal bridge, V-shaped mouth). Fifth fin-
ger clinodactyly was also observed. Generalized and se-
vere hypotonia completed her clinical profile. Head US
documented an area of encephalomalacia, compatible
with cerebral parenchymal hemorrhage occurred in the
intrauterine life. Heart and abdominal US were normal.
Soon after birth, the clinical course was marked by rele-
vant feeding problems, which needed nasogastric tube,
and thrombocytopenia, treated with platelet transfusions.
A respiratory distress syndrome appeared as well, and
required noninvasive mechanical ventilation for the first
month, and then exclusive oxygen support for further
few days. The following clinical evolution was character-
ized by persistent thrombocytopenia, lymphocytopenia
and hypogammaglobulinemia, however not associated
with further episodes of bleeding and/or infections.
aCGH analysis (100–150 Kb resolution, genomic as-
sembly GRCh37.p13) identified an 11q24.1-q25 deletion
of 11Mb, with the positions 123,414,350 and 134,868,
420 as the breakpoints of the rearrangement, associated
with a 10p15.3p13 duplication of 15Mb (from 136,145
to 15,415,339, including many genes). The deleted re-
gion is smaller than that observed in Patient 1, sparing
UBASH3B, CRTAM, JHY, BSX, HSPA8 and CLMP genes.
Both parents refused further genetic and hematological
investigations. The patient did not recover from her
feeding difficulties, and needed continuous enteral
nutrition by nasogastric tube. Hearing screening and
endocrine tests revealed normal results. Conversely,
immunological evaluation identified global lymphocyto-
penia (marked for T cells, and mild for B and NK cells),
as well as mild hypogammaglobulinemia (IgA and IgG
levels lower than normal range). She was discharged at
2 months of age, and included in a multidisciplinary
follow-up. Currently, she is 3 months old and shows nor-
mal growth and severe global developmental delay, with
deep reduction of alertness and reactivity, poor suction
and spontaneous motor activity, impaired swallowing,
severe axial hypotonia and increased muscular tone of
the limbs.
Discussion and conclusions
To date, around 25 liveborn patients with 11q23 deletion
syndrome diagnosed perinatally have been reported [6],
and the present two newborns add to the clinical data-
base. These patients manifest craniofacial dysmorphisms
(including skull deformities like macrocrania, high
prominent forehead, facial asymmetry, and commonly
observed abnormal head shape as trigonocephaly or bra-
chycephaly) [3, 7], growth/developmental delay and
brain defects, blood (thrombocytopenia, morphological
abnormalities of the platelets, coagulopathy, anemia,
lymphocytopenia) and heart disorders [6], widely
Fig. 2 a/b Patient 1. a clinodactyly of the fifth finger, enlargement and adduction of the thumb; b bilateral pes equinus varus, and crowded toes
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overlapping those of our newborns. Both present pa-
tients had pancytopenia of variable degree (including
thrombocytopenia) and neonatal bleeding. In our cases,
the presence of characteristic facial dysmorphic features,
skull deformities (brachycephaly and turricephaly) and
thrombocytopenia/pancytopenia made the diagnostic
suspicion, which was confirmed by aCGH analysis.
Although patients with the largest deletions usually
show more severe clinical manifestations and neuromo-
tor impairment, the phenotype may widely vary among
patients [3]. Indeed, both our newborns presented with
high clinical expressivity, and carried deletions (12.5
and 11Mb) encompassing the majority of JBS critical
region (about 14 Mb) and including most of the candi-
date genes. Patient 2 carried a smaller deletion than
that observed in the first newborn, sparing six genes
(UBASH3B, CRTAM, JHY, BSX, HSPA8 and CLMP)
(Fig. 3). Some of the clinical differences between our
two infants may be explained by the different number
and type of genes involved [1, 4, 8], as well as by the
concomitant presence of different risk factors (FGR,
low birth weight, perinatal asphyxia) [6], which may
have contributed to variable clinical severity (Table 1).
Specifically, among the genetic factors responsible for
the clinical variability, the contribution of the subtelo-
meric trisomy 10p to the phenotype of Patient 2 is not
clear [9]. Indeed, there is no evidence of a clearly
recognizable 10p duplication syndrome [10]. There are
few subjects with “pure” 10p duplication, as most of
them carry associated chromosomal anomalies (conse-
quence of unbalanced segregations of familial translo-
cations resulting in trisomy 10p associated with other
additional segmental imbalances) [11]. Such patients
with 10p13-p15 duplications, without other extra or
lost genes, share common features: urinary and genital
anomalies, neurological defects (microcephaly, brain
anomalies, seizures, motor delay and hypotonia), im-
munological abnormalities, vision and hearing impair-
ments, skeletal alterations (humped back, abnormal
extremities), and cleft lip/palate [10]. However, they
have variably shown to date such clinical manifestations
[9], and also our Patient 2, indeed, manifests only few
of these features (hypotonia, motor delay, hypogamma-
globulinaemia). Furthermore, in the present duplicated
genomic fragment (spanning 15Mb at 10p15.3-p13,
from 136,145 to 15,415,339) is included GATA3 gene,
whose defects (specifically its deletion) are associated to
visual and auditory deficiencies [12], however not cur-
rently observed in the proband.
Neuromotor impairment, growth delay and facial dys-
morphisms may be associated with haploinsufficiency of
ST3GAL4 (ST3 beta-galactoside alpha-2,3-sialyltransfer-
ase 4, MIM:104240) [9], KIRREL3 (kirre like nephrin
family adhesion molecule 3, MIM:607761) and BARX2
(BARX homeobox 2, MIM:604823) genes, while
thrombocytopenia and other hematopoietic defects with
that of FLI1 (Fli-1 proto-oncogene, ETS transcription
factor, MIM:193067) [2, 3, 13, 14]. They are, indeed, all
deleted in both our probands. Specifically, FLI1 has a
key role in megakaryocytes differentiation, and its
heterozygous loss is associated with dysmegakaryocyto-
poiesis and the Paris-Trousseau thrombocytopenia
(PTS) in JBS [15]. PTS is characterized by neonatal
thrombocytopenia which may resolve over time, and
platelet dysfunction (usually persistent), as well as by the
presence of two different types of abnormal platelets in
peripheral blood (giant platelets and platelets with giant
alpha granules) [16, 17]. It has been reported in the ma-
jority of JBS patients, affecting at least 88.5% of subjects,
and the platelet abnormalities found both in PTS and
JBS (and present also in our newborns) have been sup-
posed to be the same condition [3, 18]. This may not be
surprising, as JBS is a contiguous gene syndrome. ETS-1
(ETS proto-oncogene 1, transcription factor, MIM:
164720) has an essential role in heart cell migration and
development [1, 19]. However, its alteration may be not
sufficient to cause cardiac defects, since only Patient 1
(of both newborns bearing its deletion) had CHD.
Therefore, heart (ASD) and ear (hypoacusis) involve-
ment in Patient 1 may be associated to genes centro-
meric than the deleted region of Patient 2. Moreover,
TECTA (tectorin alpha, MIM:602574) gene, which is
spared by the rearrangement in both cases, is suggested
to be involved in neurosensorial deafness [3]. Nonethe-
less, in Patient 1 a mild conductive hypoacusis was
found. This may lead to consider other genes (for ex-
ample among those additionally deleted in Patient 1) in
the pathogenesis of hearing loss in JBS patients, and in
the meantime to rule out TECTA as gene associated to
conductive deafness in JBS. The deletion of two genes,
JHY (junctional cadherin complex regulator, MIM:
617594) and HSPA8 (heat shock protein family A mem-
ber 8, MIM:600816), highly expressed in the kidneys and
deleted in Patient 1 (while they are spared in Patient 2),
may explain her renal involvement (hydronephrosis).
Conversely, the more severe immunohematological pro-
file of Patient 2, presumably associated to more relevant
bleeding and major susceptibility to infections, may be
related to the genes included in 10p duplication, as well
as to other genetic (regulatory genes, alterations in in-
tronic regions or in the expression of not deleted genes)
and epigenetic factors (FGR, prematurity) [20–22]. It is
also hard to establish whether her severe neuromotor
impairment may be due to the encephalic bleeding likely
occurred during the intrauterine life, or if it is the result
of an additional deleterious effect on the phenotype of
10p13-p15 duplication, or also if it is a combination of
them both.
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Our report highlights how in some cases an effective
secondary prevention may be challenging and hard to per-
form (i.e. prenatal bleeding) [2, 6]. Then, early and continu-
ous management (obstetric, perinatal and neonatal), careful
follow-up (pediatric cardiologist and neurologist, abdominal
US to rule out pyloric stenosis and kidney and urinary tract
malformations, ophthalmological, audiological and
orthopedic evaluations, blood, immunological and endocrine
tests, oncologic surveillance) [3, 23–26], and integrated
(occupational, speech, physical and behavioral therapists)
home-based care, must be even more necessary for these pa-
tients [27, 28], whose complex clinical picture may be wors-
ened by additional concomitant factors [29]. Indeed, when
JBS cases are promptly detected (an increasing number may
Fig. 3 Schema of JBS chromosomal critical region at 11q23.3-qter, and comparison with the deletions of present newborns (red line indicates
Patient 1 deletion, blue line Patient 2 deletion)
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be perinatally suspected and diagnosed, as in present pa-
tients), it is recommended a gentle and less invasive perinatal
management, including elective cesarean section and avoid-
ance or minimal use of vascular punctures [6]. Although the
platelet count may reach low normal values (as documented
also in our newborns), a severe bleeding may occur, both in
the intrauterine life and postnatally [3, 6]. Clinicians must
anticipate and better manage medical and surgery complica-
tions (e.g. prophylactic transfusion with platelets and/or
whole blood), to reduce the mortality risk [2, 3].
To date, studies performed in JBS led to the identifica-
tion of genetic modifiers as likely contributors to the
phenotypic variability [30], in addition to differences in
deletion size. Whole genome sequencing will likely
Table 1 Comparison of the clinical and genetic features in both
patients
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Table 1 Comparison of the clinical and genetic features in both
patients (Continued)
Patient 1 Patient 2
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415,339)
GI gastrointestinal, CNS central nervous system, US ultrasound, aCGH array
comparative genomic hybridization
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provide further insights into the genetic basis of this
variability, and have important implications for therapies
[28, 31–33]. Additional risk factors, like those reported
in present newborns, must be carefully taken into ac-
count and managed by the neonatologist. He must be
aware of the potential role of such epigenetic factors,
which may increase the risk of complications and
worsen clinical evolution and outcome of patients.
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